// App-Quantinova.ai

TCT-742 : Safety and Efficacy of Ultra-thin Biodegradable Polymer-coated Everolimus-eluting Stent in Real-world Patients with Coronary Artery Disease – One-year Outcomes of Indian Multi-centric ‘EVERsafe’ Study

Researchers

Presenter

  • Manjinder Sandhu

Principal Investigators

  • P. Mangalanandan

  • Rashmit Pandya

Medical Centers

  • Artemis Hospitals, Gurgaon, Haryana, India

  • Lifecare Institute of Medical Sciences and Research, Ahmedabad, Gujarat, India

  • Cosmopolitan Hospital, Thiruvananthapuram, Kerala, British Indian Ocean Territory

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

  • Single Arm

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved